Medical Care
Global Brain Cancer Molecular Diagnostics Market Research Report 2025
- Jul 08, 25
- ID: 347421
- Pages: 79
- Figures: 74
- Views: 1
The global market for Brain Cancer Molecular Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A molecular approach for diagnosing brain cancer
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Molecular Diagnostics.
The Brain Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brain Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genetronhealth
Premed
Gene+
DMDbiomed
Helixgen
Annoroad
Geneis
Unitedgene
Inmedi
Qiagen
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A molecular approach for diagnosing brain cancer
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Molecular Diagnostics.
The Brain Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brain Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genetronhealth
Premed
Gene+
DMDbiomed
Helixgen
Annoroad
Geneis
Unitedgene
Inmedi
Qiagen
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Brain Cancer Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Brain Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Brain Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Brain Cancer Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Brain Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Brain Cancer Molecular Diagnostics Market Dynamics
2.3.1 Brain Cancer Molecular Diagnostics Industry Trends
2.3.2 Brain Cancer Molecular Diagnostics Market Drivers
2.3.3 Brain Cancer Molecular Diagnostics Market Challenges
2.3.4 Brain Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Brain Cancer Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Brain Cancer Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Brain Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Brain Cancer Molecular Diagnostics Revenue
3.4 Global Brain Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Brain Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Brain Cancer Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Brain Cancer Molecular Diagnostics, Product and Application
3.7 Global Key Players of Brain Cancer Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Brain Cancer Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Brain Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Brain Cancer Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Brain Cancer Molecular Diagnostics Market Size (2020-2031)
6.2 North America Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Cancer Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Brain Cancer Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Cancer Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genetronhealth
11.1.1 Genetronhealth Company Details
11.1.2 Genetronhealth Business Overview
11.1.3 Genetronhealth Brain Cancer Molecular Diagnostics Introduction
11.1.4 Genetronhealth Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.1.5 Genetronhealth Recent Development
11.2 Premed
11.2.1 Premed Company Details
11.2.2 Premed Business Overview
11.2.3 Premed Brain Cancer Molecular Diagnostics Introduction
11.2.4 Premed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.2.5 Premed Recent Development
11.3 Gene+
11.3.1 Gene+ Company Details
11.3.2 Gene+ Business Overview
11.3.3 Gene+ Brain Cancer Molecular Diagnostics Introduction
11.3.4 Gene+ Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.3.5 Gene+ Recent Development
11.4 DMDbiomed
11.4.1 DMDbiomed Company Details
11.4.2 DMDbiomed Business Overview
11.4.3 DMDbiomed Brain Cancer Molecular Diagnostics Introduction
11.4.4 DMDbiomed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.4.5 DMDbiomed Recent Development
11.5 Helixgen
11.5.1 Helixgen Company Details
11.5.2 Helixgen Business Overview
11.5.3 Helixgen Brain Cancer Molecular Diagnostics Introduction
11.5.4 Helixgen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.5.5 Helixgen Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Brain Cancer Molecular Diagnostics Introduction
11.6.4 Annoroad Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.6.5 Annoroad Recent Development
11.7 Geneis
11.7.1 Geneis Company Details
11.7.2 Geneis Business Overview
11.7.3 Geneis Brain Cancer Molecular Diagnostics Introduction
11.7.4 Geneis Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.7.5 Geneis Recent Development
11.8 Unitedgene
11.8.1 Unitedgene Company Details
11.8.2 Unitedgene Business Overview
11.8.3 Unitedgene Brain Cancer Molecular Diagnostics Introduction
11.8.4 Unitedgene Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.8.5 Unitedgene Recent Development
11.9 Inmedi
11.9.1 Inmedi Company Details
11.9.2 Inmedi Business Overview
11.9.3 Inmedi Brain Cancer Molecular Diagnostics Introduction
11.9.4 Inmedi Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.9.5 Inmedi Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Brain Cancer Molecular Diagnostics Introduction
11.10.4 Qiagen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.10.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Brain Cancer Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Brain Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Brain Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Brain Cancer Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Brain Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Brain Cancer Molecular Diagnostics Market Dynamics
2.3.1 Brain Cancer Molecular Diagnostics Industry Trends
2.3.2 Brain Cancer Molecular Diagnostics Market Drivers
2.3.3 Brain Cancer Molecular Diagnostics Market Challenges
2.3.4 Brain Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Brain Cancer Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Brain Cancer Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Brain Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Brain Cancer Molecular Diagnostics Revenue
3.4 Global Brain Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Brain Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Brain Cancer Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Brain Cancer Molecular Diagnostics, Product and Application
3.7 Global Key Players of Brain Cancer Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Brain Cancer Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Brain Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Brain Cancer Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Brain Cancer Molecular Diagnostics Market Size (2020-2031)
6.2 North America Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Cancer Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Brain Cancer Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Cancer Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genetronhealth
11.1.1 Genetronhealth Company Details
11.1.2 Genetronhealth Business Overview
11.1.3 Genetronhealth Brain Cancer Molecular Diagnostics Introduction
11.1.4 Genetronhealth Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.1.5 Genetronhealth Recent Development
11.2 Premed
11.2.1 Premed Company Details
11.2.2 Premed Business Overview
11.2.3 Premed Brain Cancer Molecular Diagnostics Introduction
11.2.4 Premed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.2.5 Premed Recent Development
11.3 Gene+
11.3.1 Gene+ Company Details
11.3.2 Gene+ Business Overview
11.3.3 Gene+ Brain Cancer Molecular Diagnostics Introduction
11.3.4 Gene+ Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.3.5 Gene+ Recent Development
11.4 DMDbiomed
11.4.1 DMDbiomed Company Details
11.4.2 DMDbiomed Business Overview
11.4.3 DMDbiomed Brain Cancer Molecular Diagnostics Introduction
11.4.4 DMDbiomed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.4.5 DMDbiomed Recent Development
11.5 Helixgen
11.5.1 Helixgen Company Details
11.5.2 Helixgen Business Overview
11.5.3 Helixgen Brain Cancer Molecular Diagnostics Introduction
11.5.4 Helixgen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.5.5 Helixgen Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Brain Cancer Molecular Diagnostics Introduction
11.6.4 Annoroad Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.6.5 Annoroad Recent Development
11.7 Geneis
11.7.1 Geneis Company Details
11.7.2 Geneis Business Overview
11.7.3 Geneis Brain Cancer Molecular Diagnostics Introduction
11.7.4 Geneis Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.7.5 Geneis Recent Development
11.8 Unitedgene
11.8.1 Unitedgene Company Details
11.8.2 Unitedgene Business Overview
11.8.3 Unitedgene Brain Cancer Molecular Diagnostics Introduction
11.8.4 Unitedgene Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.8.5 Unitedgene Recent Development
11.9 Inmedi
11.9.1 Inmedi Company Details
11.9.2 Inmedi Business Overview
11.9.3 Inmedi Brain Cancer Molecular Diagnostics Introduction
11.9.4 Inmedi Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.9.5 Inmedi Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Brain Cancer Molecular Diagnostics Introduction
11.10.4 Qiagen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)
11.10.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Brain Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Brain Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Brain Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Brain Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Brain Cancer Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Brain Cancer Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Brain Cancer Molecular Diagnostics Market Trends
Table 13. Brain Cancer Molecular Diagnostics Market Drivers
Table 14. Brain Cancer Molecular Diagnostics Market Challenges
Table 15. Brain Cancer Molecular Diagnostics Market Restraints
Table 16. Global Brain Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Brain Cancer Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Brain Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Brain Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Brain Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Brain Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Brain Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Brain Cancer Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Brain Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Brain Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Genetronhealth Company Details
Table 49. Genetronhealth Business Overview
Table 50. Genetronhealth Brain Cancer Molecular Diagnostics Product
Table 51. Genetronhealth Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Genetronhealth Recent Development
Table 53. Premed Company Details
Table 54. Premed Business Overview
Table 55. Premed Brain Cancer Molecular Diagnostics Product
Table 56. Premed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Premed Recent Development
Table 58. Gene+ Company Details
Table 59. Gene+ Business Overview
Table 60. Gene+ Brain Cancer Molecular Diagnostics Product
Table 61. Gene+ Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Gene+ Recent Development
Table 63. DMDbiomed Company Details
Table 64. DMDbiomed Business Overview
Table 65. DMDbiomed Brain Cancer Molecular Diagnostics Product
Table 66. DMDbiomed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 67. DMDbiomed Recent Development
Table 68. Helixgen Company Details
Table 69. Helixgen Business Overview
Table 70. Helixgen Brain Cancer Molecular Diagnostics Product
Table 71. Helixgen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Helixgen Recent Development
Table 73. Annoroad Company Details
Table 74. Annoroad Business Overview
Table 75. Annoroad Brain Cancer Molecular Diagnostics Product
Table 76. Annoroad Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Annoroad Recent Development
Table 78. Geneis Company Details
Table 79. Geneis Business Overview
Table 80. Geneis Brain Cancer Molecular Diagnostics Product
Table 81. Geneis Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Geneis Recent Development
Table 83. Unitedgene Company Details
Table 84. Unitedgene Business Overview
Table 85. Unitedgene Brain Cancer Molecular Diagnostics Product
Table 86. Unitedgene Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 87. Unitedgene Recent Development
Table 88. Inmedi Company Details
Table 89. Inmedi Business Overview
Table 90. Inmedi Brain Cancer Molecular Diagnostics Product
Table 91. Inmedi Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Inmedi Recent Development
Table 93. Qiagen Company Details
Table 94. Qiagen Business Overview
Table 95. Qiagen Brain Cancer Molecular Diagnostics Product
Table 96. Qiagen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Qiagen Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Brain Cancer Molecular Diagnostics Picture
Figure 2. Global Brain Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Brain Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Brain Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Brain Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Brain Cancer Molecular Diagnostics Report Years Considered
Figure 14. Global Brain Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Brain Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Brain Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Brain Cancer Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Brain Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Brain Cancer Molecular Diagnostics Revenue in 2024
Figure 20. North America Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Brain Cancer Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Genetronhealth Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 50. Premed Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 51. Gene+ Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 52. DMDbiomed Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 53. Helixgen Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 54. Annoroad Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 55. Geneis Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 56. Unitedgene Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 57. Inmedi Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 58. Qiagen Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Brain Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Brain Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Brain Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Brain Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Brain Cancer Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Brain Cancer Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Brain Cancer Molecular Diagnostics Market Trends
Table 13. Brain Cancer Molecular Diagnostics Market Drivers
Table 14. Brain Cancer Molecular Diagnostics Market Challenges
Table 15. Brain Cancer Molecular Diagnostics Market Restraints
Table 16. Global Brain Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Brain Cancer Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Brain Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Brain Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Brain Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Brain Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Brain Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Brain Cancer Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Brain Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Brain Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Genetronhealth Company Details
Table 49. Genetronhealth Business Overview
Table 50. Genetronhealth Brain Cancer Molecular Diagnostics Product
Table 51. Genetronhealth Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Genetronhealth Recent Development
Table 53. Premed Company Details
Table 54. Premed Business Overview
Table 55. Premed Brain Cancer Molecular Diagnostics Product
Table 56. Premed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Premed Recent Development
Table 58. Gene+ Company Details
Table 59. Gene+ Business Overview
Table 60. Gene+ Brain Cancer Molecular Diagnostics Product
Table 61. Gene+ Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Gene+ Recent Development
Table 63. DMDbiomed Company Details
Table 64. DMDbiomed Business Overview
Table 65. DMDbiomed Brain Cancer Molecular Diagnostics Product
Table 66. DMDbiomed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 67. DMDbiomed Recent Development
Table 68. Helixgen Company Details
Table 69. Helixgen Business Overview
Table 70. Helixgen Brain Cancer Molecular Diagnostics Product
Table 71. Helixgen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Helixgen Recent Development
Table 73. Annoroad Company Details
Table 74. Annoroad Business Overview
Table 75. Annoroad Brain Cancer Molecular Diagnostics Product
Table 76. Annoroad Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Annoroad Recent Development
Table 78. Geneis Company Details
Table 79. Geneis Business Overview
Table 80. Geneis Brain Cancer Molecular Diagnostics Product
Table 81. Geneis Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Geneis Recent Development
Table 83. Unitedgene Company Details
Table 84. Unitedgene Business Overview
Table 85. Unitedgene Brain Cancer Molecular Diagnostics Product
Table 86. Unitedgene Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 87. Unitedgene Recent Development
Table 88. Inmedi Company Details
Table 89. Inmedi Business Overview
Table 90. Inmedi Brain Cancer Molecular Diagnostics Product
Table 91. Inmedi Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Inmedi Recent Development
Table 93. Qiagen Company Details
Table 94. Qiagen Business Overview
Table 95. Qiagen Brain Cancer Molecular Diagnostics Product
Table 96. Qiagen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Qiagen Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Brain Cancer Molecular Diagnostics Picture
Figure 2. Global Brain Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Brain Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Brain Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Brain Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Brain Cancer Molecular Diagnostics Report Years Considered
Figure 14. Global Brain Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Brain Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Brain Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Brain Cancer Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Brain Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Brain Cancer Molecular Diagnostics Revenue in 2024
Figure 20. North America Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Brain Cancer Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Genetronhealth Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 50. Premed Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 51. Gene+ Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 52. DMDbiomed Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 53. Helixgen Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 54. Annoroad Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 55. Geneis Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 56. Unitedgene Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 57. Inmedi Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 58. Qiagen Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Cutting Machines for Diamond Market Research Report 2025
Jul 18, 25
Global RF Shielded Enclosures Market Research Report 2025
Jul 18, 25
Global Padel Court Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232